Small interfering RNA and molecular inhibitors of the mismatch repair gene MutL Homolog 1 (MLH1) suppressed colon cancer sensitivity to cetuximab treatment via PI3K/AKT signalling [11]. The gene discussed is AKT1; the disease is colonic neoplasm.